Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02399995 · ClinicalTrials.gov registry record
Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time
A clinical trial of Colorectal Liver Metastasis, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 219
- Enrollment target
- 7
- Study locations
NCT02399995: Active study of Colorectal Liver Metastasis, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02399995 is a study of Colorectal Liver Metastasis that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 219 participants. The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02399995, a study of Colorectal Liver Metastasis, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 219 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is being done to learn more about health related quality of life factors in people having surgery for colorectal liver metastasis. The investigators will look at how these factors may change over time. The information gained from this study will help the investigators to understand the long-term effects that cancer treatments have on the health related quality of life of patients. This information is of high value and will help doctors talk to patients about the possible effects of their operations. While many patients live a long time after such operations, the studies that have been done do not tell the full story of what patients go through after surgery. This study will help us to understand cancer treatment from the patient's perspective. It will also help cancer patients make better decisions about their treatment options and will help them know what to expect after the operation.
Primary Outcome
in patients at high risk of recurrence undergoing hepatectomy to assess health related quality of life (HRQoL) using the EORTC QLQ-C30, QLQ-LMC21 and the EuroQol EQ-5D-5L, in patients at high risk of recurrence undergoing hepatectomy for colorectal liver metastasis and to evaluate global and disease specific changes over time.
Conditions Studied
Interventions
- BEHAVIORAL HRQoL questionnaires.
Study Locations (7)
New York
- Memorial Sloan Kettering Commack (Consent and Follow up) - Commack
- Memorial Sloan Kettering Westchester (Consent and Follow Up) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (Consent and follow up) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent and Follow up) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent and Follow up) - Middletown
- Memorial Sloan Kettering Bergen (Consent and Follow up) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2015-03 |
| Est. Completion | 2026-03 |
What the registry record for NCT02399995 still lists
NCT02399995 is an observational study that tracks outcomes without assigning an intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Colorectal Liver Metastasis appearing as the primary indexed condition, and to 1 intervention - of which HRQoL questionnaires. is the first listed.
NCT02399995 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT02399995 about?
NCT02399995 is a clinical study titled "Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time". This study is being done to learn more about health related quality of life factors in people having surgery for colorectal liver metastasis. The investigators will look at how these factors may change over time. The information gained from this study will help the investigators to understand the lo...
What is the current status of trial NCT02399995?
This trial is currently active not recruiting. The enrollment target is 219 participants. The study started on 2015-03. Estimated completion is 2026-03.
What conditions does trial NCT02399995 study?
This clinical trial studies the following conditions: Colorectal Liver Metastasis.
What interventions are being tested in trial NCT02399995?
The interventions under investigation include: HRQoL questionnaires. (BEHAVIORAL).
Who is sponsoring clinical trial NCT02399995?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02399995 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05196035 · 219 participants · Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- NCT05608434 · 219 participants · Phase 1
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- NCT05773144 · 219 participants · NA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- NCT05907980 · 219 participants · Phase 1
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia